408 results on '"Kantor, Paul F."'
Search Results
2. Criss-Cross Heart
3. Cardiac imaging and biomarkers for assessing myocardial fibrosis in children with hypertrophic cardiomyopathy
4. QTc and QRS Abnormalities are Associated with Outcome in Pediatric Heart Failure
5. Drug Treatment of Heart Failure in Children: Gaps and Opportunities
6. Baseline Characteristics of Pediatric Patients With Heart Failure Due to Systemic Left Ventricular Systolic Dysfunction in the PANORAMA-HF Trial
7. Non-invasive biomarkers of Fontan-associated liver disease
8. The Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy
9. Abstract 13633: Differences in Right and Left Ventricular Remodeling After Tetralogy of Fallot Repair in Patients With and Without Pulmonary Valve Replacement
10. Abstract 11615: The Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy
11. Association Between Serial B-Type Natriuretic Peptide Levels, Vasoactive Drug Weaning, and Adverse Cardiovascular Outcomes in Pediatric Heart Failure.
12. Cardiac biomarkers in pediatric cardiomyopathy: Study design and recruitment results from the Pediatric Cardiomyopathy Registry
13. Shedding Light on the Darkness of MYH7 Cardiomyopathies
14. Genetic Evaluation of Cardiomyopathy—A Heart Failure Society of America Practice Guideline
15. No Obesity Paradox in Pediatric Patients With Dilated Cardiomyopathy
16. Progressive Left Ventricular Remodeling for Predicting Mortality in Children With Dilated Cardiomyopathy: The Pediatric Cardiomyopathy Registry.
17. Abstract 14410: A Machine Learning Approach to Predicting Risk of Anthracycline Cardiotoxicity in Pediatric Cancer Survivors
18. A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy
19. Self-reported and Accelerometer-Measured Physical Activity in Children With Cardiomyopathy
20. The clinical impact of donor-specific antibodies on antibody-mediated rejection and long-term prognosis after heart transplantation
21. Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)
22. DECLINING SERIAL B-TYPE NATRIURETIC PEPTIDE LEVEL PREDICTS SUCCESSFUL WEANING OF VASOACTIVE THERAPY IN PEDIATRIC ACUTE DECOMPENSATED HEART FAILURE
23. Risk of Sudden Death in Patients With RASopathy Hypertrophic Cardiomyopathy
24. Incidence, Severity, and Association With Adverse Outcome of Hyponatremia in Children Hospitalized With Heart Failure
25. Future research directions in pediatric cardiomyopathy
26. Update on pediatric heart failure
27. List of Contributors
28. Outpatient Management of Pediatric HF
29. Cardiomyopathy Phenotypes and Outcomes for Children With Left Ventricular Myocardial Noncompaction: Results From the Pediatric Cardiomyopathy Registry
30. Abnormal Myocardial Contractility After Pediatric Heart Transplantation by Cardiac MRI
31. The Subpulmonary Right Ventricle in Chronic Left Ventricular Failure
32. Prevalence, predictors, and outcomes of cardiorenal syndrome in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry
33. Incidence and impact of malnutrition in patients with Fontan physiology
34. Abstract 16673: Exome Sequencing in a Pediatric Cardiomyopathy Cohort: Findings From the Pediatric Cardiomyopathy Registry
35. Abstract 16567: Are Echocardiogram and Magnetic Resonance Imaging (MRI) Comparable in Measuring Maximal Septal Thickness in Children With Hypertrophic Cardiomyopathy (HCM)?
36. Abstract 16563: Fibrosis and Hypertrophy Assessed by Magnetic Resonance Imaging (MRI) and Serum Biomarkers in Pediatric Hypertrophic Cardiomyopathy (HCM). A Report From the Pediatric Cardiomyopathy Registry Group
37. Abstract 16472: Cardiac Biomarkers Are Associated With Death and Listing for Heart Transplantation in Pediatric Patients With Newly Diagnosed Dilated Cardiomyopathy: A Multi-Center Study From the Pediatric Cardiomyopathy Registry
38. The Utility of Cardiopulmonary Exercise Testing for the Prediction of Outcomes in Ambulatory Children With Dilated Cardiomyopathy
39. Maturation of fatty acid and carbohydrate metabolism in the newborn heart
40. Current applications and future needs for biomarkers in pediatric cardiomyopathy and heart failure: Summary from the Second International Conference on Pediatric Cardiomyopathy
41. Biomarkers in pediatric heart failure: Their role in diagnosis and evaluating disease progression
42. Usefulness of Mitral Regurgitation as a Marker of Increased Risk for Death or Cardiac Transplantation in Idiopathic Dilated Cardiomyopathy in Children
43. Effectiveness of Serial Increases in Amino-Terminal Pro–B-Type Natriuretic Peptide Levels to Indicate the Need for Mechanical Circulatory Support in Children With Acute Decompensated Heart Failure
44. The genetic architecture of pediatric cardiomyopathy
45. Incidence and impact of malnutrition in patients with Fontan physiology.
46. Pathophysiology and Management of Heart Failure in Repaired Congenital Heart Disease
47. Mitogenic cardiomyopathy: A lethal neonatal familial dilated cardiomyopathy characterized by myocyte hyperplasia and proliferation
48. Abstract 9202: Sudden Cardiac Death and Icd Use in Rasopathy-Associated Hypertrophic Cardiomyopathy: An International Multi-Centre Study
49. Recent and Upcoming Drug Therapies for Pediatric Heart Failure
50. Acute cellular rejection in pediatric heart transplant recipients is associated with abnormal left ventricular mechanics by CMR
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.